Show simple item record

Impact of End-to-End Lead Time on Service Level and Working Capital in a Pharmaceutical Company

dc.contributor.authorGirsch, Thilo
dc.contributor.authorBautista, Kristin
dc.date.accessioned2016-03-31T18:15:54Z
dc.date.available2016-03-31T18:15:54Z
dc.date.issued2016-03-31
dc.identifier.urihttp://hdl.handle.net/1721.1/102016
dc.language.isoenen_US
dc.relation.ispartofseriesSCALE Research Reports;ZLC-2012-1
dc.rightsAttribution 4.0 International (CC BY 4.0)
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectend-to-end lead time
dc.subjectworking capital optimization
dc.titleImpact of End-to-End Lead Time on Service Level and Working Capital in a Pharmaceutical Companyen_US
dc.typeThesisen_US


Files in this item

Thumbnail
Name:
2012_1_Bautista_Girsch.pdf
Size:
504.9Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record